Invitrogen

Cytokeratin Pan Antibody Cocktail

Advanced Verification

This Antibody was verified by Relative expression to ensure that the antibody binds to the antigen stated.

6 Published Figures

33 References

View all (71) Cytokeratin Pan Type I/II antibodies

Datasheet

Protocols

Questions & Answers

Datasheet

Protocols

Questions & Answers

Cytokeratin Pan Antibody in Immunocytochemistry (ICC/IF)

FIGURE: 1 / 18

Cytokeratin Pan Antibody (MA5-13203) in ICC/IF

Immunofluorescence analysis of Cytokeratin Pan was performed using 70% confluent log phase A-431 cells. The cells were fixed and permeabilized with ice-cold acetone at 4°C for 5 minutes, and blocked with 2% BSA for 1 hour at room temperature. The cells were labeled with Cytokeratin Pan Antibody Cocktail (Product # MA5-13203, 5 µg/mL) in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with... View More

Cytokeratin Pan Antibody in Immunohistochemistry (Paraffin) (IHC (P))

Cytokeratin Pan Antibody in Western Blot (WB)

Cytokeratin Pan Antibody in Western Blot, Immunocytochemistry (WB, ICC/IF)

Cytokeratin Pan Antibody in Immunohistochemistry (IHC)

Product Image Gallery

Product Details

MA5-13203

Applications

Tested Dilution

Publications

Western Blot (WB)

1:1,000-1:5,000

View 4 publications 4 publications

Immunohistochemistry (IHC)

View 14 publications 14 publications

Immunohistochemistry (Paraffin) (IHC (P))

1-2 µg/mL

Immunohistochemistry (Frozen) (IHC (F))

View 1 publication 1 publication

Immunocytochemistry (ICC/IF)

1:20-1:200

View 12 publications 12 publications

Flow Cytometry (Flow)

View 1 publication 1 publication

Miscellaneous PubMed (Misc)

View 1 publication 1 publication

Product Specifications

Species Reactivity

Human, Mouse

Published species

Fish, Guinea pig, Human, Mouse, Pig

Host/Isotype

Mouse / IgG, kappa

Class

Cocktail

Type

Antibody

Clone

PAN-CK

Immunogen

Human epidermal keratins

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.2 mg/mL

Purification

Protein A/G

Storage buffer

PBS, pH 7.4, with 0.05% BSA

Contains

0.05% sodium azide

Storage conditions

4° C

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_10942225

Product Specific Information

This antibody is a broad-spectrum pan-keratin monoclonal antibody cocktail which recognizes keratin 4, 5, 6, 7, 8, 10, 13, 14, 18 and 19. This product can differentiate between epithelial and non-epithelial tumors.

For staining of formalin-fixed tissue,digest sections wtih trypsin at 1 mg/mL in PBS, 10 min at 37ºC, or Protease XXV at 1 mg/mL in PBS for 5 min at 37ºC.

Target Information

Cytokeratin pan is part of a subfamily of intermediate filament proteins that are characterized by remarkable biochemical diversity, and represented in human epithelial tissues by at least 20 different polypeptides. Cytokeratins range in molecular weight between 40 kDa- 68 kDa, and an isoelectric pH between 4.9-7.8. The individual human cytokeratins are numbered 1 to 20. The various epithelia in the human body usually express cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. The composition of cytokeratin pairs vary with the epithelial cell type, stage of differentiation, cellular growth environment, and disease state. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Product References

Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition.

Journal of cancer research and clinical oncology

Kapeleris J,Müller Bark J,Ranjit S,Richard D,Vela I,O'Byrne K,Punyadeera C

MA5-13203 was used in Western Blotting to suggest that when investigating CTCs as a prognostic biomarker in NSCLC, it is also essential to take into consideration EMT status to obtain a comprehensive overview of CTCs in circulation.

Thu Dec 01 00:00:00 EST 2022

Use of Single Cell Transcriptomic Techniques to Study the Role of High-Risk Human Papillomavirus Infection in Cervical Cancer.

Frontiers in immunology

Meng L,Chen S,Shi G,He S,Wang Z,Shen J,Wang J,Sooranna SR,Zhao J,Song J

MA5-13203 was used in Immunohistochemistry-immunofluorescence to provide a basis for the development of a rational post-operative follow-up programme and the development of an appropriate treatment plan for patients with cervical cancer.

Fri Jul 01 00:00:00 EDT 2022

Resveratrol and Its Analogue 4,4'-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model.

Biomedicines

Savio M,Ferraresi A,Corpina C,Vandenberghe S,Scarlata C,Sottile V,Morini L,Garavaglia B,Isidoro C,Stivala LA

MA5-13203 was used in Immunohistochemistry to conclude that Resveratrol, and its analogue 4,4'-dihydroxystilbene, could be employed to synergise with conventional oncotherapies to limit the contribution of stromal cells in tumour growth.

Mon Jul 25 00:00:00 EDT 2022

In vitro and in vivo correlation of skin and cellular responses to nucleic acid delivery.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Bosnjak M,Znidar K,Sales Conniff A,Jesenko T,Markelc B,Semenova N,Tur J,Kohena K,Kranjc Brezar S,Heller L,Cemazar M

MA5-13203 was used in Immunohistochemistry-frozen immunofluorescence to investigate the immune response in skin cells, including keratinocytes, fibroblasts, and macrophages, following plasmid DNA electrotransfer, revealing upregulation of DNA sensors and cytokines.

Wed Jun 01 00:00:00 EDT 2022

Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.

Cell death and differentiation

Yang S,Li H,Yao H,Zhang Y,Bao H,Wu L,Zhang C,Li M,Feng L,Zhang J,Zheng Z,Xu G,Wang F

MA5-13203 was used in Immunocytochemistry to study the role of a long noncoding RNA (lncRNA) named epithelial-mesenchymal transition-related lncRNA in etinal pigment epithelial (ERLR, LINC01705-201 (ENST00000438158.1)) in proliferative vitreoretinopathy and to explore the underlying mechanisms.

Sun Aug 01 00:00:00 EDT 2021

Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.

Cancer control : journal of the Moffitt Cancer Center

Li X,Dean DC,Ferreira A,Nelson SD,Hornicek FJ,Yu S,Duan Z

Published figure using Cytokeratin Pan cocktail antibody (Product # MA5-13203) in Western Blot

Fri Jan 21 00:00:00 EST 2022

The keratin-desmosome scaffold: pivotal role of desmosomes for keratin network morphogenesis.

Cellular and molecular life sciences : CMLS

Moch M,Schwarz N,Windoffer R,Leube RE

MA5-13203 was used in Immunocytochemistry-immunoflourescence to examine details of Desmosome-anchored keratin intermediate filaments (KFs) attachment and network organization in epithelial coherence and its coupling to desmosome formation.

Sat Feb 01 00:00:00 EST 2020

Comprehensive Immune Profiling of Medullary Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association

Pozdeyev N,Erickson TA,Zhang L,Ellison K,Rivard CJ,Sams S,Hirsch FR,Haugen BR,French JD

MA5-13203 was used in Immunohistochemistry to suggest that medullary thyroid cancer (MTC) is a more immunologically active tumor that has been previously reported.

Tue Sep 01 00:00:00 EDT 2020

Establishment of iPSC lines from a high-grade Klinefelter Syndrome patient (49-XXXXY) and two genetically matched healthy relatives (KAUSTi003-A, KAUSTi004-A, KAUSTi004-B, KAUSTi005-A, KAUSTi005-B, KAUSTi005-C).

Stem cell research

Alowaysi M,Fiacco E,Astro V,Adamo A

MA5-13203 was used in Immunohistochemistry to derived iPSC lines from a high-grade 49-XXXXY Klinefelter Syndrome and two healthy donors' fibroblasts.

Tue Dec 01 00:00:00 EST 2020

Generation of two iPSC lines (KAUSTi001-A, KAUSTi002-A) from a rare high-grade Klinefelter Syndrome patient (49-XXXXY) carrying a balanced translocation t(4,11) (q35,q23).

Stem cell research

Alowaysi M,Fiacco E,Astro V,Adamo A

MA5-13203 was used in Immunocytochemistry to generate two iPSC lines 48-XXXY and 49-XXXXY from a non-mosaic 49-XXXXY KS patient carrying a balanced translocation t(4,11) (q35,q23).

Tue Dec 01 00:00:00 EST 2020

Generation of iPSC lines (KAUSTi011-A, KAUSTi011-B) from a Saudi patient with epileptic encephalopathy carrying homozygous mutation in the GLP1R gene.

Stem cell research

Alowaysi M,Astro V,Fiacco E,Alzahrani F,Alkuraya FS,Adamo A

MA5-13203 was used in Immunocytochemistry to establish two iPSC lines from a patient harbouring a rare homozygous splice site variant in GLP1R for use as a model to study the molecular pathology of GLP1R dysfunction.

Mon Dec 28 00:00:00 EST 2020

Establishment of an iPSC cohort from three unrelated 47-XXY Klinefelter Syndrome patients (KAUSTi007-A, KAUSTi007-B, KAUSTi009-A, KAUSTi009-B, KAUSTi010-A, KAUSTi010-B).

Stem cell research

Alowaysi M,Fiacco E,Astro V,Adamo A

MA5-13203 was used in Immunocytochemistry to describe the derivation of multiple 47-XXY iPSC lines from three unrelated KS patients to study the impact of supernumerary X chromosome during early development.

Tue Dec 01 00:00:00 EST 2020

Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY).

Stem cell research

Fiacco E,Alowaysi M,Astro V,Adamo A

MA5-13203 was used in Flow cytometry/Cell sorting to show that using naturally isogenic iPSCs from mosaic Klinefelter Syndrome patients to compare disease and healthy cells carrying a virtually identical genomic background.

Tue Dec 01 00:00:00 EST 2020

BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases.

Neoplasia (New York, N.Y.)

Grigore F,Yang H,Hanson ND,VanBrocklin MW,Sarver AL,Robinson JP

MA5-13203 was used in Immunohistochemistry-immunofluorescence to study resistance to BRAF inhibition.

Tue Sep 01 00:00:00 EDT 2020

BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases.

Neoplasia (New York, N.Y.)

Grigore F,Yang H,Hanson ND,VanBrocklin MW,Sarver AL,Robinson JP

MA5-13203 was used in Immunohistochemistry-immunofluorescence to study resistance to BRAF inhibition.

Tue Sep 01 00:00:00 EDT 2020

Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.

PloS one

Yong C,Moose DL,Bannick N,Gutierrez WR,Vanneste M,Svensson R,Breheny P,Brown JA,Dodd RD,Cohen MB,Henry MD

MA5-13203 was used in Immunohistochemistry to monitor the progression of prostate cancer in mice using non-invasive bioluminescent imaging.

Tue Oct 27 00:00:00 EDT 2020

Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.

PloS one

Yong C,Moose DL,Bannick N,Gutierrez WR,Vanneste M,Svensson R,Breheny P,Brown JA,Dodd RD,Cohen MB,Henry MD

MA5-13203 was used in Immunohistochemistry to monitor the progression of prostate cancer in mice using non-invasive bioluminescent imaging.

Tue Oct 27 00:00:00 EDT 2020

A DNA Vaccine Expressing Consensus Hemagglutinin-Esterase Fusion Protein Protected Guinea Pigs from Infection by Two Lineages of Influenza D Virus.

Journal of virology

Wan Y,Kang G,Sreenivasan C,Daharsh L,Zhang J,Fan W,Wang D,Moriyama H,Li F,Li Q

MA5-13203 was used in Immunohistochemistry to design a DNA vaccine expressing consensus hemagglutinin-esterase fusion protein, and test its protective efficacy against two lineages of influenza D virus in guinea pigs.

Fri Jun 01 00:00:00 EDT 2018

A DNA Vaccine Expressing Consensus Hemagglutinin-Esterase Fusion Protein Protected Guinea Pigs from Infection by Two Lineages of Influenza D Virus.

Journal of virology

Wan Y,Kang G,Sreenivasan C,Daharsh L,Zhang J,Fan W,Wang D,Moriyama H,Li F,Li Q

Fri Jun 01 00:00:00 EDT 2018

Characterisation of mesenchymal colon tumour-derived cells in tumourspheres as a model for colorectal cancer progression.

International journal of oncology

Turano M,Costabile V,Cerasuolo A,Duraturo F,Liccardo R,Delrio P,Pace U,Rega D,Dodaro CA,Milone M,Izzo P,De Rosa M

Published figure using Cytokeratin Pan cocktail antibody (Product # MA5-13203) in Immunofluorescence

Sat Dec 01 00:00:00 EST 2018

FGF10 Is Required for Circumvallate Papilla Morphogenesis by Maintaining Lgr5 Activity.

Frontiers in physiology

Zhang S,Choi HS,Jung HS,Lee JM

MA5-13203 was used in Immunohistochemistry to suggest that the crosstalk between epithelial Lgr5 and mesenchymal Fgf10 plays a pivotal role in CVP epithelium invagination during mouse tongue CVP development by maintaining Lgr5-positive stem/progenitor cells.

Thu Oct 01 00:00:00 EDT 2020

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion.

Oncogene

Berens EB,Sharif GM,Schmidt MO,Yan G,Shuptrine CW,Weiner LM,Glasgow E,Riegel AT,Wellstein A

MA513203 was used in immunocytochemistry and western blot to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion

Thu Feb 02 00:00:00 EST 2017

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion.

Oncogene

Berens EB,Sharif GM,Schmidt MO,Yan G,Shuptrine CW,Weiner LM,Glasgow E,Riegel AT,Wellstein A

MA513203 was used in immunocytochemistry and western blot to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion

Thu Feb 02 00:00:00 EST 2017

The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation.

Scientific reports

Aprile FA,Källstig E,Limorenko G,Vendruscolo M,Ron D,Hansen C

MA5-13203 was used in Western Blotting to demonstrate that a CRISPR/Cas9-mediated knockout of DNAJB6, in HEK293T cells expressing α-syn, causes a massive increase in α-syn aggregation.

Tue Aug 22 00:00:00 EDT 2017

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.

Stem cell research & therapy

Katanov C,Lerrer S,Liubomirski Y,Leider-Trejo L,Meshel T,Bar J,Feniger-Barish R,Kamer I,Soria-Artzi G,Kahani H,Banerjee D,Ben-Baruch A

MA5-13203 was used in western blot to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells

Fri May 01 00:00:00 EDT 2015

Efficient Generation of Mice with Consistent Transgene Expression by FEEST.

Scientific reports

Gao L,Jiang Y,Mu L,Liu Y,Wang F,Wang P,Zhang A,Tang N,Chen T,Luo M,Yu L,Gao S,Chen L

MA5-13203 was used in immunohistochemistry - paraffin section to describe functionally enriched ES cell transgenics

Tue Nov 17 00:00:00 EST 2015

Glucocorticoid treatment independently affects expansion and transdifferentiation of porcine neonatal pancreas cell clusters.

BMB reports

Kim JW,Sun C,Jeon SY,You YH,Shin JY,Lee SH,Cho JH,Park CG,Yoon KH

MA5-13203 was used in Immunohistochemistry to determine the effects of duration and timing of glucocorticoid treatment on the expansion and differentiation of porcine neonatal pancreas cell clusters into β-cells.

Sun Jan 01 00:00:00 EST 2012

Epithelioid leiomyosarcoma with rhabdoid features.

Wiener klinische Wochenschrift

Yorulmaz G,Erdogan G,Pestereli HE,Savas B,Karaveli FS

MA5-13203 was used in immunohistochemistry to report on a case of epithelioid leiomyosarcoma with rhabdoid features

Wed Jan 30 00:00:00 EST 2008

Fine needle aspiration cytology of inflammatory myofibroblastic tumour (inflammatory pseudotumour) of the breast: a case report and review of the literature.

Cytopathology : official journal of the British Society for Clinical Cytology

Akbulut M,Gunhan-Bilgen I,Zekioglu O,Duygulu G,Oktay A,Ozdemir N

MA5-13203 was used in immunohistochemistry to investigate a clinical case of inflammatory myofibroblastic tumour in the breast

Sat Dec 01 00:00:00 EST 2007

Incidental calcifying fibrous tumor of the stomach presenting as a polyp.

Pathology international

Elpek GO,Küpesiz GY,Ogüs M

MA5-13203 was used in immunohistochemistry to report on a case of incidental calcifying fibrous tumor of the stomach presenting as a polyp

Sat Apr 01 00:00:00 EST 2006

Ovarian ependymoma.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Erdoğan G,Ozel E,Peştereli HE,Salar Z,Tirak B,Karaveli S

MA5-13203 was used in immunohistochemistry to report on a case of anaplastic ependymoma.

Fri Apr 01 00:00:00 EST 2005

Persistent infection of betanodavirus in a novel cell line derived from the brain tissue of barramundi Lates calcarifer.

Diseases of aquatic organisms

Chi SC,Wu YC,Cheng TM

MA5-13203 was used in immunocytochemistry to establish and characterize a novel cell line infected with betanodavirus

Wed Jun 01 00:00:00 EDT 2005

Mediastinal intraoperative radioisotope sentinel lymph node mapping in non-small-cell lung cancer.

Nuclear medicine communications

Atinkaya C,Ozlem Küçük N,Koparal H,Aras G,Sak SD,Ozdemir N

MA5-13203 was used in immunohistochemistry to develop a method to map sentinel lymph nodes in non-small cell lung cancer patients

Mon Aug 01 00:00:00 EDT 2005

Efficacy of a recombinant chimeric anti-hCG antibody to prevent human cytotrophoblasts fusion and block progesterone synthesis.

American journal of reproductive immunology (New York, N.Y. : 1989)

Dhar R,Karmakar S,Sriraman R,Talwar GP,Das C

MA5-13203 was used in immunocytochemistry to study the use of a recombinant chimeric anti-hCG antibody to neutralize the bioactivity of hCG on human trophoblasts

Sat May 01 00:00:00 EDT 2004

Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes.

Cancer letters

Sashiyama H,Shino Y,Sakao S,Shimada H,Kobayashi S,Ochiai T,Shirasawa H

MA5-13203 was used in immunocytochemistry to study the role of the integrins in the malignant progression of human papillomavirus-immortalized esophageal keratinocytes

Fri Mar 08 00:00:00 EST 2002

Bioinformatics

Protein Aliases: 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; Cell proliferation-inducing gene 46 protein; CK-1; CK-10; CK-13; CK-14; CK-15; CK-16; CK-17; CK-18; CK-19; CK-1B; CK-2e; CK-2P; CK-3; CK-4; CK-5; CK-6A; CK-6D; CK-7; CK-8; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 2; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; Cytokeratin 7; cytokeratin 8; Cytokeratin endo A; Cytokeratin endo B; Cytokeratin-1; Cytokeratin-10; Cytokeratin-13; Cytokeratin-14; Cytokeratin-15; Cytokeratin-16; Cytokeratin-17; Cytokeratin-18; Cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; Cytokeratin-2P; Cytokeratin-3; Cytokeratin-4; Cytokeratin-5; Cytokeratin-6A; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; Cytokeratin-7; Cytokeratin-8; Cytoskeletal 57 kDa keratin; embryonic type II keratin 1; Embryonic type II keratin-1; Endo B; epidermal keratin 10; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; Epithelial keratin-2e; focal non-epidermolytic palmoplantar keratoderma; Hair alpha protein; HMWCK; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K2e; K2P; K3; K4; K5; K6A; K7; K76; K77; K8; kamp-keratin derived antimicrobial peptide; KDAMP; keratin 1, type II; keratin 10, type I; keratin 13, type I; keratin 14, type I; keratin 15, type I; keratin 16, type I; keratin 17, type I; keratin 18, type I; keratin 19, type I; Keratin 1B; keratin 2 epidermis; keratin 2, type II; keratin 2p; keratin 3, type II; keratin 4, type II; keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin 6A, , type II; keratin 6A, type II; keratin 7, type II; keratin 76, type II; keratin 77, type II; keratin 8, type II; keratin 86; keratin complex 1, acidic, gene 10; keratin complex 1, acidic, gene 13; keratin complex 1, acidic, gene 14; keratin complex 1, acidic, gene 15; keratin complex 1, acidic, gene 16; keratin complex 1, acidic, gene 17; keratin complex 1, acidic, gene 18; keratin complex 1, acidic, gene 19; keratin complex 2, basic, gene 1; keratin complex 2, basic, gene 17; keratin complex 2, basic, gene 39; keratin complex 2, basic, gene 4; keratin complex 2, basic, gene 5; keratin complex 2, basic, gene 6a; keratin complex 2, basic, gene 6c; keratin complex 2, basic, gene 7; keratin complex 2, basic, gene 8; keratin complex 2, gene 17; keratin complex 2, gene 6a; Keratin D; keratin intermediate filament 16a; keratin intermediate filament 16b; keratin K6h; Keratin type II cytoskeletal 5; keratin, 55K type II cytoskeletal; keratin, epidermal type II, K6A; keratin, simple epithelial type I, K7; Keratin, type I cytoskeletal 10; Keratin, type I cytoskeletal 13; Keratin, type I cytoskeletal 14; Keratin, type I cytoskeletal 15; Keratin, type I cytoskeletal 16; Keratin, type I cytoskeletal 17; Keratin, type I cytoskeletal 18; Keratin, type I cytoskeletal 19; Keratin, type I cytoskeletal 59 kDa; keratin, type I, 40-kd; Keratin, type II cytoskeletal 1; Keratin, type II cytoskeletal 1b; Keratin, type II cytoskeletal 2 epidermal; Keratin, type II cytoskeletal 2 oral; Keratin, type II cytoskeletal 3; Keratin, type II cytoskeletal 4; Keratin, type II cytoskeletal 5; Keratin, type II cytoskeletal 6A; Keratin, type II cytoskeletal 7; Keratin, type II cytoskeletal 8; Keratin-1; Keratin-10; Keratin-13; Keratin-14; Keratin-15; keratin-15, basic; keratin-15, beta; Keratin-16; Keratin-17; Keratin-18; Keratin-19; Keratin-2 epidermis; Keratin-2e; Keratin-3; Keratin-4; Keratin-5; Keratin-6-alpha; Keratin-6A; keratin-6C; Keratin-7; Keratin-76; Keratin-77; Keratin-8; KRT1B; krt2; krt5; krt7; krt76; mK6-alpha; pan Cytokeratin; pan keratin; pankeratin; Sarcolectin; suprabasal cytokeratin 10; tuftelin interacting protein 8; type I cytoskeletal 15; type II cytoskeletal 1b; type II keratin Kb39; type II mesothelial keratin K7; type-II intermediate filament protein; Type-II keratin Kb1; type-II keratin Kb12; Type-II keratin Kb2; Type-II keratin Kb3; Type-II Keratin Kb39; Type-II keratin Kb4; Type-II keratin Kb5; Type-II keratin Kb6; Type-II keratin Kb7; Type-II keratin Kb8; Type-II keratin Kb9

View more View less

Gene Aliases: 2310001L23Rik; 2310016L08Rik; 3300001P10Rik; 39.1; 4732484G22Rik; AA960620; AI324768; AI528832; AI626930; AI663979; AL022697; AU019895; AW108092; AW146334; BB005427; BCIE; BIE; CARD2; CK-17; CK-18; CK-2e; CK-4; CK-6C; CK-6E; CK-8; CK1; CK10; CK13; CK14; CK15; CK16; CK18; CK19; CK3; CK4; CK5; CK6A; CK6C; CK6D; CK7; CK8; CYK18; CYK4; CYK8; D130054E02Rik; D15Wsu77e; DDD; DDD1; EBS2; EBS3; EBS4; EHK; EHK1; EndoA; EndoC; EPPK; FNEPPK; HUMCYT2A; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K1emb; K2C7; K2C8; K2e; K3; K4; K5; K6A; K6C; K6D; K7; K8; Ker2; Kerd; KO; KPP; Krt-1.10; Krt-1.13; Krt-1.14; Krt-1.19; Krt-2.1; Krt-2.4; Krt-2.8; KRT1; Krt1-10; Krt1-13; Krt1-14; Krt1-15; Krt1-16; Krt1-17; Krt1-18; Krt1-19; KRT10; KRT13; KRT14; KRT15; KRT16; KRT16A; KRT17; KRT18; KRT19; KRT1A; KRT1B; KRT2; Krt2-1; Krt2-17; Krt2-2; Krt2-4; Krt2-5; Krt2-6; Krt2-6a; Krt2-6c; Krt2-7; Krt2-8; Krt239; KRT2A; KRT2B; KRT2E; KRT2P; KRT3; KRT4; KRT5; KRT5A; Krt6; KRT6A; KRT6C; KRT6D; KRT7; KRT76; KRT77; KRT8; Krt86; KRTA; KRTB; KRTE; mK1b; mK6[a]; MK6a; NEPPK; NFJ; PC; PC1; PC2; PC3; PCHC1; PIG46; SCL; Tfip8; WSN1; WSN2

View more View less

Function(s)

receptor activity structural molecule activity protein binding carbohydrate binding structural constituent of epidermis structural constituent of cytoskeleton keratin filament binding scaffold protein binding MHC class II receptor activity MHC class II protein binding poly(A) RNA binding cadherin binding involved in cell-cell adhesion structural constituent of muscle protein complex binding molecular_function protein heterodimerization activity

Process(es)

epithelial cell differentiation intermediate filament cytoskeleton organization morphogenesis of an epithelium signal transduction positive regulation of cell growth hair follicle morphogenesis keratinization intermediate filament organization positive regulation of translation positive regulation of hair follicle development complement activation, lectin pathway retina homeostasis response to oxidative stress fibrinolysis regulation of angiogenesis negative regulation of inflammatory response establishment of skin barrier mitophagy in response to mitochondrial depolarization cytoskeleton organization cellular response to calcium ion cell cycle anatomical structure morphogenesis viral process tumor necrosis factor-mediated signaling pathway Golgi to plasma membrane CFTR protein transport negative regulation of apoptotic process extrinsic apoptotic signaling pathway hepatocyte apoptotic process cell-cell adhesion biological_process embryo development negative regulation of epithelial cell proliferation epidermis development sebaceous gland development aging response to zinc ion response to ionizing radiation hemidesmosome assembly hair cycle intermediate filament bundle assembly immune system process inflammatory response keratinocyte differentiation negative regulation of cell migration innate immune response keratinocyte migration Notch signaling pathway response to estrogen sarcomere organization cell differentiation involved in embryonic placenta development keratinocyte activation keratinocyte proliferation cell morphogenesis involved in differentiation multicellular organism development response to hydrostatic pressure response to other organism Wnt signaling pathway wound healing cell proliferation response to radiation tongue morphogenesis cellular response to retinoic acid

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more

Cytokeratin Pan Antibody Cocktail

Cytokeratin Pan Antibody (MA5-13203) in ICC/IF

Product Details

MA5-13203

Western Blot (WB)

Immunohistochemistry (IHC)

Immunohistochemistry (Paraffin) (IHC (P))

Immunohistochemistry (Frozen) (IHC (F))

Immunocytochemistry (ICC/IF)

Flow Cytometry (Flow)

Miscellaneous PubMed (Misc)

Species Reactivity

Published species

Host/Isotype

Class

Type

Clone

Immunogen

Conjugate

Form

Concentration

Purification

Storage buffer

Contains

Storage conditions

Shipping conditions

RRID

Product Specific Information

Target Information

Bioinformatics

Performance Guarantee

We're here to help

Your items have has been added!